OXULAR LIMITED
Company number 09331313 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£55,421,556
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2014-11-27
- Employees
- 8 (2025 accounts)
- Registered office
- The Charter Building, Vine Street, Uxbridge, Middlesex, England, UB8 1JG
- Postcode
- UB8 1JG
- Capital
- 450 GBP
- Accounts category
- Small
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-11-19
- Next due by
- 2026-12-03
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 7 current · 10 resigned
Subscribers only
Director
Subscribers only
Director
Subscribers only
Director
Subscribers only
Director
Subscribers only
Director
Group structure 1 subsidiary
Controlled by Regeneron Pharmaceuticals, Inc. (01226128) — since 2024-12-20
From persons-with-significant-control filings on the public register.
Contact details
- Website
- oxular.net
Previous company names
| Name | Date changed |
|---|---|
| PRECISION OCULAR LTD | 2016-10-10 |
Previous registered addresses 2
| Address | Changed on |
|---|---|
| MAGDALEN HOUSE 1 ROBERT ROBINSON AVENUE, OXFORD, OX4 4GA, ENGLAND | 2016-08-12 |
| RIVERBANK HOUSE 2 SWAN LANE, LONDON, EC4R 3TT | 2016-05-27 |
Among its peers
Top 25%
by shareholders' funds, of 9 similar companies in UB
Trading since 2014.
Competitors Hayes
-
4. NEOHAIR LTD
This company ranks 1 among research and experimental development on biotechnology in Hayes.
The class of 2014
38%
of the 356 companies in this sector incorporated in 2014 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.